ZBTB20 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	48 studies	51% ± 27%	Explore
fibroblast	42 studies	48% ± 27%	Explore
B cell	29 studies	33% ± 20%	Explore
pericyte	28 studies	49% ± 24%	Explore
smooth muscle cell	26 studies	49% ± 26%	Explore
mast cell	22 studies	53% ± 23%	Explore
astrocyte	21 studies	88% ± 11%	Explore
endothelial cell of lymphatic vessel	20 studies	51% ± 25%	Explore
memory B cell	17 studies	27% ± 8%	Explore
macrophage	16 studies	49% ± 23%	Explore
microglial cell	16 studies	69% ± 19%	Explore
oligodendrocyte	15 studies	88% ± 9%	Explore
oligodendrocyte precursor cell	15 studies	84% ± 17%	Explore
CD8-positive, alpha-beta T cell	15 studies	26% ± 13%	Explore
ciliated cell	14 studies	39% ± 23%	Explore
T cell	14 studies	39% ± 26%	Explore
CD4-positive, alpha-beta T cell	14 studies	30% ± 17%	Explore
capillary endothelial cell	14 studies	40% ± 21%	Explore
epithelial cell	12 studies	43% ± 24%	Explore
basal cell	12 studies	42% ± 27%	Explore
GABAergic neuron	11 studies	60% ± 21%	Explore
endothelial cell of artery	11 studies	44% ± 19%	Explore
vein endothelial cell	11 studies	50% ± 21%	Explore
naive B cell	10 studies	19% ± 3%	Explore
adipocyte	10 studies	81% ± 16%	Explore
endothelial cell of vascular tree	10 studies	43% ± 24%	Explore
glutamatergic neuron	9 studies	48% ± 24%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	9 studies	30% ± 18%	Explore
neuron	9 studies	47% ± 28%	Explore
connective tissue cell	9 studies	38% ± 18%	Explore
myofibroblast cell	9 studies	45% ± 21%	Explore
mesothelial cell	9 studies	64% ± 26%	Explore
natural killer cell	9 studies	37% ± 18%	Explore
regulatory T cell	9 studies	31% ± 18%	Explore
type I pneumocyte	8 studies	64% ± 25%	Explore
dendritic cell	8 studies	46% ± 16%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	22% ± 6%	Explore
club cell	7 studies	53% ± 25%	Explore
retinal cone cell	7 studies	46% ± 25%	Explore
retinal rod cell	7 studies	57% ± 29%	Explore
type II pneumocyte	7 studies	62% ± 27%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	18% ± 3%	Explore
plasma cell	6 studies	42% ± 21%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	37% ± 19%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	6 studies	20% ± 6%	Explore
glial cell	6 studies	49% ± 29%	Explore
interneuron	6 studies	62% ± 10%	Explore
myeloid cell	6 studies	43% ± 22%	Explore
retina horizontal cell	6 studies	62% ± 25%	Explore
retinal ganglion cell	6 studies	60% ± 31%	Explore
cardiac muscle cell	6 studies	79% ± 16%	Explore
Mueller cell	6 studies	85% ± 14%	Explore
monocyte	6 studies	54% ± 16%	Explore
abnormal cell	6 studies	46% ± 23%	Explore
CD16-positive, CD56-dim natural killer cell, human	5 studies	26% ± 14%	Explore
leukocyte	5 studies	71% ± 24%	Explore
retinal bipolar neuron	5 studies	62% ± 24%	Explore
amacrine cell	5 studies	52% ± 22%	Explore
innate lymphoid cell	5 studies	46% ± 20%	Explore
lymphocyte	5 studies	50% ± 22%	Explore
T follicular helper cell	5 studies	22% ± 5%	Explore
gamma-delta T cell	5 studies	23% ± 1%	Explore
hematopoietic stem cell	5 studies	25% ± 6%	Explore
ionocyte	4 studies	45% ± 13%	Explore
secretory cell	4 studies	21% ± 4%	Explore
type B pancreatic cell	4 studies	31% ± 14%	Explore
cholangiocyte	4 studies	85% ± 7%	Explore
hepatocyte	4 studies	83% ± 15%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	40% ± 21%	Explore
conventional dendritic cell	4 studies	28% ± 13%	Explore
granule cell	4 studies	78% ± 24%	Explore
progenitor cell	4 studies	62% ± 24%	Explore
retinal pigment epithelial cell	4 studies	76% ± 22%	Explore
OFF-bipolar cell	4 studies	65% ± 20%	Explore
ON-bipolar cell	4 studies	65% ± 18%	Explore
Schwann cell	4 studies	58% ± 27%	Explore
chondrocyte	4 studies	56% ± 31%	Explore
mature NK T cell	4 studies	39% ± 26%	Explore
muscle cell	4 studies	58% ± 30%	Explore
myoepithelial cell	4 studies	50% ± 30%	Explore
kidney loop of Henle epithelial cell	4 studies	61% ± 36%	Explore
renal principal cell	4 studies	67% ± 32%	Explore
endothelial cell of sinusoid	3 studies	43% ± 15%	Explore
hepatic stellate cell	3 studies	77% ± 11%	Explore
classical monocyte	3 studies	18% ± 2%	Explore
glomerular endothelial cell	3 studies	31% ± 0%	Explore
differentiation-committed oligodendrocyte precursor	3 studies	81% ± 14%	Explore
GABAergic interneuron	3 studies	35% ± 7%	Explore
Purkinje cell	3 studies	64% ± 24%	Explore
endocardial cell	3 studies	61% ± 27%	Explore
mucosal invariant T cell	3 studies	43% ± 22%	Explore
GABAergic amacrine cell	3 studies	57% ± 14%	Explore
glycinergic amacrine cell	3 studies	52% ± 14%	Explore
rod bipolar cell	3 studies	93% ± 7%	Explore
CD4-positive helper T cell	3 studies	23% ± 4%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	25% ± 10%	Explore
luminal cell of prostate epithelium	3 studies	42% ± 27%	Explore
pancreatic A cell	3 studies	25% ± 2%	Explore
pancreatic ductal cell	3 studies	56% ± 3%	Explore
ependymal cell	3 studies	91% ± 5%	Explore
adventitial cell	3 studies	66% ± 10%	Explore
alveolar macrophage	3 studies	55% ± 9%	Explore
respiratory goblet cell	3 studies	62% ± 21%	Explore
brush cell	3 studies	35% ± 9%	Explore
epithelial cell of proximal tubule	3 studies	75% ± 30%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	69% ± 32%	Explore
parietal epithelial cell	3 studies	82% ± 23%	Explore
renal alpha-intercalated cell	3 studies	79% ± 28%	Explore
mural cell	3 studies	77% ± 16%	Explore
mucus secreting cell	3 studies	66% ± 13%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	18 studies	61% ± 19%	Explore
lung	13 studies	36% ± 22%	Explore
eye	9 studies	61% ± 27%	Explore
heart	6 studies	67% ± 20%	Explore
pancreas	4 studies	28% ± 10%	Explore
liver	4 studies	52% ± 25%	Explore
peripheral blood	4 studies	26% ± 5%	Explore
breast	4 studies	40% ± 16%	Explore
intestine	4 studies	17% ± 1%	Explore
adipose	4 studies	60% ± 33%	Explore
kidney	4 studies	75% ± 25%	Explore
uterus	3 studies	31% ± 11%	Explore
lymph node	3 studies	20% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	87%	190.03	1255 / 1445	80%	2.31	147 / 183
ovary	100%	496.78	180 / 180	67%	1.43	287 / 430
brain	95%	221.74	2513 / 2642	55%	1.60	385 / 705
kidney	100%	242.26	89 / 89	41%	1.27	373 / 901
stomach	84%	139.49	302 / 359	50%	1.72	144 / 286
prostate	100%	368.71	245 / 245	22%	0.89	112 / 502
breast	99%	351.55	455 / 459	23%	0.70	257 / 1118
thymus	100%	458.95	653 / 653	16%	0.25	95 / 605
lung	98%	241.72	568 / 578	14%	0.99	164 / 1155
intestine	92%	208.00	887 / 966	19%	0.61	100 / 527
pancreas	98%	255.63	322 / 328	6%	0.17	11 / 178
bladder	100%	185.95	21 / 21	3%	0.52	16 / 504
adrenal gland	100%	272.96	257 / 258	1%	0.02	3 / 230
uterus	99%	341.12	168 / 170	1%	0.07	6 / 459
muscle	100%	335.37	802 / 803	0%	0	0 / 0
adipose	100%	313.65	1200 / 1204	0%	0	0 / 0
blood vessel	99%	256.55	1321 / 1335	0%	0	0 / 0
skin	97%	226.31	1747 / 1809	1%	0.02	7 / 472
liver	93%	144.72	211 / 226	2%	0.03	9 / 406
heart	95%	255.99	821 / 861	0%	0	0 / 0
spleen	81%	100.54	195 / 241	0%	0	0 / 0
peripheral blood	53%	89.63	494 / 929	0%	0	0 / 0
tonsil	0%	0	0 / 0	2%	0.03	1 / 45
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
eye	0%	0	0 / 0	0%	0	0 / 80
gingiva	0%	0	0 / 0	0%	0	0 / 0
lymph node	0%	0	0 / 0	0%	0	0 / 29
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0071333	Biological process	cellular response to glucose stimulus
GO_0032728	Biological process	positive regulation of interferon-beta production
GO_0010629	Biological process	negative regulation of gene expression
GO_0046889	Biological process	positive regulation of lipid biosynthetic process
GO_0002682	Biological process	regulation of immune system process
GO_0000122	Biological process	negative regulation of transcription by RNA polymerase II
GO_0001817	Biological process	regulation of cytokine production
GO_0055088	Biological process	lipid homeostasis
GO_0045821	Biological process	positive regulation of glycolytic process
GO_0032760	Biological process	positive regulation of tumor necrosis factor production
GO_0032755	Biological process	positive regulation of interleukin-6 production
GO_0005654	Cellular component	nucleoplasm
GO_0016604	Cellular component	nuclear body
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0000978	Molecular function	RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO_0001227	Molecular function	DNA-binding transcription repressor activity, RNA polymerase II-specific
GO_0000976	Molecular function	transcription cis-regulatory region binding
GO_1990837	Molecular function	sequence-specific double-stranded DNA binding
GO_0046872	Molecular function	metal ion binding

IV. Literature review

[source]

Gene name	ZBTB20
Protein name	Zinc finger and BTB domain containing 20 Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288)
Synonyms	DPZF ZNF288
Description	FUNCTION: May be a transcription factor that may be involved in hematopoiesis, oncogenesis, and immune responses . Plays a role in postnatal myogenesis, may be involved in the regulation of satellite cells self-renewal (By similarity). .
Accessions	ENST00000676079.1 [Q9HC78-1] ENST00000471418.5 [Q9HC78-2] ENST00000470311.6 [Q9HC78-2] C9JUH0 ENST00000482689.5 ENST00000464560.5 [Q9HC78-2] ENST00000704358.1 [Q9HC78-1] ENST00000474710.6 [Q9HC78-1] C9JCX0 ENST00000704360.1 ENST00000357258.8 [Q9HC78-2] ENST00000462705.5 [Q9HC78-2] A0A994J4D3 ENST00000470311.6 Q9HC78 ENST00000675478.1 [Q9HC78-1] ENST00000481632.5 [Q9HC78-2]

ZBTB20 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review